97 -5 (79) 2025 - Khayrullaeva G.S. - FEATURES OF OBESITY DEVELOPMENT IN PATIENTS WHO HAVE PASSED COVID-19

FEATURES OF OBESITY DEVELOPMENT IN PATIENTS WHO HAVE PASSED COVID-19

Khayrullaeva G.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The purpose of this study is to study the clinical and pathogenetic mechanisms of lipid metabolism disorders and obesity development in patients who have had COVID-19, as well as to analyze modern approaches to their correction. Under the conditions of the SARS-CoV-2 pandemic, there is a significant increase in metabolic disorders, including post-COVID obesity associated with an inflammatory cascade, endocrine system dysfunction, and decreased physical activity. The work examines the molecular mechanisms of these disorders and proposes directions for their medicamental and non-medicamental correction.

Keywords: COVID-19, lipid metabolism, obesity, insulin resistance, metabolic syndrome, correction, rehabilitation.

First page

488

Last page

492

For citation:Khayrullaeva G.S. - FEATURES OF OBESITY DEVELOPMENT IN PATIENTS WHO HAVE PASSED COVID-19//New Day in Medicine 5(79)2025 488-492 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Бондарь В. Н., Ефременкова Л. Н., Чернышова Е. С. Клинико-патогенетические особенности дислипидемии при артериальной гипертензии в сочетании с метаболическим синдромом //Вісник проблем біології і медицини. – 2012. – Т. 1. – №. 3. – С. 43-45.
  2. Бубнова М. Г. и др. Реабилитация после новой коронавирусной инфекции (COVID-19): принципы и подходы // CardioСоматика. 2020. – Т. 11. – №. 4. – С. 6-14.
  3. Вялкова А. А. и др. Клинико-патогенетические аспекты повреждения почек при ожирении (обзор литературы) //Нефрология. – 2014. – Т. 18. – №. 3. – С. 24-33.
  4. Кручинина М. В. и др. Последствия коронавирусной инфекции: гемореологические нарушения и возможности их коррекции // Consilium Medicum. – 2024. – Т. 26. – №. 11. – С. 719-732.
  5. Fericean R. M. et al. Characterization and outcomes of SARS-CoV-2 infection in overweight and obese patients: A dynamic comparison of COVID-19 pandemic waves // Journal of Clinical Medicine. – 2022. – Т. 11. – №. 10. – С. 2916.
  6. Földi M. et al. Obesity is a risk factor for developing critical condition in COVID‐19 patients: a systematic review and meta‐analysis // Obesity Reviews. – 2020. – Т. 21. – №. 10. – С. e13095.
  7. Huang Y. et al. Obesity in patients with COVID-19: a systematic review and meta-analysis // Metabolism. – 2020. – Т. 113. – С. 154378.

    file

    download